在患有鼻息肉的慢性鼻炎中局部皮质类固醇的坚持,在dupilumab治疗的患者中
S M Miotti1, C Brà Hlmann1, A Yalamanoglu2
1University Hospital of Zurich, Department of Otorhinolaryngology, Head and Neck Surgery, Zurich, Switzerland;University of Zurich, Zurich, Switzerland.
患者使用dupilumab治疗严重的慢性鼻炎与鼻息肉 (CRSwNP) 和喘可能对局部皮质类固醇的依附性较低. 这项研究调查了与杜皮卢马布治疗同时使用鼻内 (INCS) 和吸入 (ICS) 皮质类固醇的坚持.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 诸如dupilumab这样的生物药物已经改变了严重的慢性鼻炎与鼻息肉 (CRSwNP) 和喘管理.
- 局部皮质类固醇,包括鼻内 (INCS) 和吸入 (ICS) 皮质类固醇,在治疗这些疾病方面仍然至关重要.
- 有限的数据存在于CRSwNP和喘的症状控制局部皮质类固醇和dupilumab的联合坚持.
研究的目的:
- 在用dupilumab治疗的CRSwNP和喘患者中评估INCS和ICS的药物坚持.
- 在这个患者群体中探索局部皮质类固醇的坚持和症状控制之间的关系.
主要方法:
- 这项研究的重点是评估药物坚持模式.
- 数据收集可能涉及患者调查或处方补充记录.
- 分析将与临床结果相关联的坚持率.
主要成果:
- 该研究假设基于一般慢性疾病的坚持趋势,INCS和ICS的坚持率较低.
- 杜皮卢马布的显著疗效可能会掩盖局部皮质类固醇坚持的潜在问题.
结论:
- 在接受dupilumab的CRSwNP和喘患者中,INCS和ICS的低坚持可能很普遍.
- 优化对局部皮质类固醇的坚持对于与生物疗法并行的综合性症状管理至关重要.
更多相关视频
07:36Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
Published on: July 3, 2025
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
